In the present study, we employed protein engineering strategies to optimize the bacterial expression and PEGylation of the human enzyme thymidine phosphorylase, an enzyme that could be used as a scaffold for the treatment of MNGIE, an inborn error of metabolism with high unmet medical need. This evidence concerns the gene TYMP and mitochondrial neurogastrointestinal encephalomyopathy.